Clinical Trial Update: Sensing Using Neutrophil Activation Probe on the Intensive Therapy Unit [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating a neutrophil activation probe for sensing in lung disease patients, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Disease

Snippet

Sponsor: University of Edinburgh | Conditions: Lung Disease | Phase 2 | Status: COMPLETED